Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02737046 · ClinicalTrials.gov registry record · Phase 2
Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma
A Phase 2 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT02737046 is a Phase 2 study that has completed, run by University of Miami. The registered enrollment target is 15 participants.
The verdict
NCT02737046, a Phase 2 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
The investigators propose to use Belinostat in combination with AZT as consolidation therapy for the treatment of ATLL.
Interventions
- DRUG Zidovudine
- DRUG Belinostat
- DRUG Interferon-Alfa-2b
- DRUG Pegylated Interferon-Alfa-2b
- DRUG Lymphodepleting Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-12-12 |
| Est. Completion | 2025-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02737046
The ClinicalTrials.gov registry entry for NCT02737046 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Zidovudine is the first listed.
NCT02737046 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02737046 about?
NCT02737046 is a clinical study titled "Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma". The investigators propose to use Belinostat in combination with AZT as consolidation therapy for the treatment of ATLL.
What is the current status of trial NCT02737046?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2016-12-12. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT02737046?
The interventions under investigation include: Zidovudine (DRUG), Belinostat (DRUG), Interferon-Alfa-2b (DRUG), Pegylated Interferon-Alfa-2b (DRUG), Lymphodepleting Therapy (DRUG).
Who is sponsoring clinical trial NCT02737046?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.